Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neur... Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.29 | 5.07880910683 | 5.71 | 6.8299 | 5.15 | 1138473 | 6.00206301 | CS |
| 4 | -2.37 | -28.3154121864 | 8.37 | 8.82 | 5.035 | 1065233 | 6.82574414 | CS |
| 12 | -1.95 | -24.5283018868 | 7.95 | 9.06 | 5.035 | 924275 | 7.0570064 | CS |
| 26 | -4.95 | -45.2054794521 | 10.95 | 12.22 | 5.035 | 1083512 | 8.0216146 | CS |
| 52 | -11.59 | -65.8897100625 | 17.59 | 17.99 | 5.035 | 794013 | 9.56610673 | CS |
| 156 | -24.66 | -80.4305283757 | 30.66 | 35.73 | 5.035 | 565348 | 15.60973611 | CS |
| 260 | -28.5 | -82.6086956522 | 34.5 | 50.26 | 5.035 | 496278 | 21.99180967 | CS |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
